Skip to main content
News Icon

News categories: Honors & Funding

Funding success for international Research Training Group

Joint project by Universities of Bonn and Melbourne extended until 2025

Launched in 2016, the international Research Training Group of the Universities of Bonn and Melbourne will now continue to receive funding until 2025.

This was confirmed by the German Research Foundation (DFG). The joint project facilitates the training of young researchers in an excellent academic environment at two globally distinguished research locations. The Research Training Group examines the role of certain immune cells in infections, tumor diseases, autoimmunity and vaccinations. The international Research Training Group allows doctoral students to establish an international network early on. The doctoral students are part of a structured program in which they are mentored by two senior researchers in Bonn and Melbourne. Of an average of three years of doctoral studies, the doctoral students spend one year at the partner university. Graduates are awarded a joint PhD of the Universities of Bonn and Melbourne.

"We are very happy that we can continue our successful cooperation. With this extension, the DFG is honoring the added value of international partnerships and the performance of our doctoral students. The entire team is very proud of this success," says Prof. Dr. Christian Kurts, Leibniz laureate and speaker of the Research Training Group in Bonn.

Obtaining a doctorate at the only German immunological Cluster of Excellence ImmunoSensation2 can be even more attractive for young researchers when they are given the opportunity to conduct one year of their research at one of Australia's leading universities. This is exactly what the German-Australian Research Training Group "Bonn & Melbourne Research and Graduate School Immunosciences" (ITRG 2168) has been offering since funding was confirmed by the DFG in April 2016.

Contact

Prof. Dr. Christian Kurts

Phone: +49 228 287-11050

Email: iei@uni-bonn.de

Related news

Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview